We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Anthony
Quinn
anthony.quinn@psych.ox.ac.uk
Rachel
Upthegrove
rachel.upthegrove@psych.ox.ac.uk
Schizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The NIHR Severe Mental Illness Longitudinal Evaluation (SMILE) BioResource is a collaborative project between the NIHR, the University of Oxford, Cardiff University, King’s College London and the University of Birmingham for the Mental Health Translational Research Collaboration (MH-TRC). Severe Mental Illness (SMI) is a term that includes mental health disorders such as psychosis spectrum disorders, schizophrenia, schizoaffective disorders, and severe mood disorders with psychotic symptoms. We do not understand enough about the causes of SMI, whether diagnostic structures are biologically valid, and how best to target new treatments.
Data collection for the SMILE BioResource will take place in the company of a trained research nurse/ clinical researcher. A trained research nurse/ clinical researcher will collect a blood or saliva sample, questionnaire data, responses to a cognitive task, and medical notes from people with SMI to create a resource to support studies investigating biological, social, and environment factors that influence the risk of a person experiencing SMI, and the symptoms they have. Patients with SMI will be invited to consent to:
- donating either a blood sample or a saliva sample at a routine clinical appointment
- completing self-report measures of symptoms and a Health and Lifestyle Questionnaire
- relevant information being gathered from their health records, and other records by the treating team
- contact for recall to future studies based on their data and biological sample
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
An individual will not be enrolled as a study participant if: • They are unable to provide a blood sample or a saliva sample. • They are unable to complete the study measures (as assessed by a clinician/clinical researcher).
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Oxford and funded by NIHR Mental Health Translational Research Collaboration .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 66308
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
